Alex Cranberg serves as Managing Director at Sporos Bioventures, LLC. See contact routes.
Alex Cranberg serves as Managing Director at Sporos Bioventures, LLC, a private biotechnology company strategically focused on revolutionizing the drug development landscape within oncology. Through a distinctive portfolio approach, Sporos Bioventures holds significant equity interests in multiple biopharmaceutical entities. This includes Tvardi Therapeutics and Sporos BioDiscovery, both integral to the firm's mission. Cranberg's work at Sporos Bioventures contributes to its efforts to transform the drug development process. The firm operates from Houston, Texas, United States, aligning with its venture capital activities in the biotechnology sector.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Houston when building a target list.
Investors like Alex Cranberg · Full investor directory · Investor access · Company funding database